Core Viewpoint - The stock of Kefu Medical (301087) has shown a decline in price and mixed capital flow, with a notable increase in retail investor inflow despite overall net outflows from institutional and speculative funds [1][2]. Group 1: Stock Performance - As of November 17, 2025, Kefu Medical's stock closed at 42.97 yuan, down 1.24% with a turnover rate of 0.85% and a trading volume of 16,600 hands, resulting in a transaction amount of 71.06 million yuan [1]. - Over the past five days, the stock has experienced fluctuations in price and capital flow, with significant net outflows from both institutional and speculative investors, while retail investors showed a net inflow [1]. Group 2: Financial Metrics - Kefu Medical's total market capitalization is 8.976 billion yuan, with a net asset value of 4.75 billion yuan and a net profit of 260 million yuan, ranking 43rd, 29th, and 24th respectively in the medical device industry [2]. - The company reported a year-on-year revenue increase of 6.63% for the first three quarters of 2025, with a total revenue of 2.398 billion yuan and a net profit increase of 3.3% [2]. - The gross profit margin stands at 53.35%, and the net profit margin is 10.82%, indicating strong profitability compared to industry averages [2]. Group 3: Analyst Ratings - In the last 90 days, nine institutions have rated Kefu Medical with a "buy" recommendation, and the average target price set by these institutions is 53.84 yuan [3].
股票行情快报：可孚医疗（301087）11月17日主力资金净卖出67.74万元